Latham & Watkins represented the underwriters in the offering. Eliem Therapeutics, Inc., a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to...
Eliem Therapeutics’ $80 Million Initial Public Offering
European Wax Center’s $207.2 Million Initial Public Offering
Paul, Weiss advised European Wax Center, while Latham & Watkins represented the underwriters in the offering. European Wax Center, Inc. and certain selling stockholders executed its...
Adagio Therapeutics’ $356 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. Adagio Therapeutics, Inc. executed the initial public offering of 20,930,000 shares of its common stock at...
Immuneering’s US$129.4 Million IPO
Sidley Austin advised the underwriters on the deal, while Choate and Latham & Watkins assisted Immuneering Corporation. Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a...
Xponential Fitness’ $120 Million Initial Public Offering
Davis Polk advised Xponential Fitness in its IPO, while Latham & Watkins represented the underwriters. Xponential Fitness, Inc. executed its $120 million initial public offering of 10,000,000...
Shoals Technologies Group’s $375 Million Stock Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in the offering. Shoals Technologies Group, Inc. and certain selling stockholders executed the $375 million SEC-registered offering...
Clarios International’s Initial Pubic Offering
Cleary Gottlieb represented the underwriters, led by BofA Securities and J.P. Morgan, in the initial public offering. Clarios International Inc. (“Clarios”), a world leader in advanced...
IDEAYA Biosciences’ $92 Million Common Stock Offering
Latham & Watkins advised IDEAYA Biosciences, while Davis Polk advised the underwriters in the offering. IDEAYA Biosciences, Inc. executed its public offering of 5,333,333 shares of common...
Logistics Innovation Technologies’ $300 Million Initial Public Offering
Davis Polk advised Guggenheim Securities, LLC acting as the sole bookrunner in the transaction. Logistics Innovation Technologies Corp. executed its $300 million initial public offering of 34,089,611...
Logistics Innovation Technologies’ $300 Million Initial Public Offering
Davis Polk advised Guggenheim Securities, LLC acting as the sole bookrunner in the transaction. Logistics Innovation Technologies Corp. executed its $300 million initial public offering of 34,089,611...
Monte Rosa Therapeutics’ $222.3 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Monte Rosa Therapeutics, Inc. executed its initial public offering of 11,700,000 shares of common stock at a...
Leslie’s Secondary Offering
Latham & Watkins LLP represented the underwriters in the offering. Leslie’s, Inc., the largest direct-to-consumer brand in the US pool and spa care industry, serving residential,...